Diamond Hill Capital filed a regulatory disclosure on Feb. 6 showing a 1.25% reduction in its HCA Healthcare position. The cut represents the firm’s latest portfolio rebalancing move, slightly lowering its exposure to the hospital operator.

While the trimming is modest, it may reflect caution on future industry trends or valuation levels. Institutional buying and selling patterns can influence market sentiment and potentially weigh on share performance in the short term.